Alaunos Therapeutics, Inc. (TCRT) — 分析师展望 / 分析师共识目标价为. 基于 10 位分析师评级, 共识为 中性 — 1 买入, 8 持有, 1 卖出.
分析师预估 每股收益(EPS)为 $-6.00 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.92 vs 预期 $-6.00 (超预期 +51.3%). 2025: 实际 $-2.20 vs 预期 $-19.50 (超预期 +88.7%). 分析师准确度: 0%.
TCRT 分析师评级
Hold
基于过去3个月内 10 位分析师对 Alaunos Therapeutics, Inc. 的评级
EPS 预测 — TCRT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.92
vs Est –$6.00
▲ 105.5% off
2025
Actual –$2.20
vs Est –$19.50
▲ 786.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — TCRT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 0.0% off
2025
Actual $0.000B
vs Est $0.557B
▼ 11,138,420.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
